A Paradigm Shift In Container Closure Integrity Of Parenteral Drugs
By Oliver Stauffer, CEO , PTI Inspection
If there is a leak or breach of the sterile barrier, environmental contaminants can rapidly convert a life-saving treatment into a microbial soup. The latest evolution of HVLD, PTI’s patent pending MicroCurrent technology, aims to achieve a high level of CCI assurance across the entire range of parenteral products.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.
Subscribe to Med Device Online X
Subscribe to Med Device Online